Albemarle CORP
Market Movers (8-K)
NYSE
Albemarle Corporation announced the appointment of Eduardo Bartolomeo to its Board of Directors, effective July 21, 2026, bringing extensive mining and logistics leadership experience.
NYSE
Albemarle Corporation shareholders approved the 2026 Incentive Plan and elected directors at the May 5, 2026, Annual Meeting.
NYSE
Albemarle Corporation announced a significant increase in first quarter 2026 net sales and adjusted EBITDA, primarily fueled by strong performance in its Energy Storage and Specialties segments.
Better than expected
NYSE
Albemarle Corporation announced that Chief Accounting Officer Donald J. LaBauve Jr. will retire effective June 1, 2026.
NYSE
Albemarle Corporation amended its credit agreement, extending the maturity date to October 2028 and removing a 0.10% SOFR interest adjustment.
NYSE
Albemarle Corporation completed the sale of a controlling stake in Ketjen and launched cash tender offers and a redemption for its senior notes to reduce debt.
Quarterly Earnings (10-Q)
NYSE
Albemarle Corporation reported a significant increase in net income and revenue for the first quarter of 2026, driven by strong performance in its Energy Storage segment, primarily due to higher lithium pricing.
Better than expected
NYSE
Albemarle Corporation reported significantly improved gross profit and reduced net loss in Q3 2025, driven by lower input costs and restructuring efforts, alongside plans to divest its Refining Solutions business.
Delay expected
Better than expected
Capital raise
NYSE
Albemarle Corporation reported significantly improved financial results for Q2 2025 and the first half of 2025, narrowing net losses and increasing cash flow from operations, driven by cost reductions and strategic asset optimization despite continued lithium market price pressures.
Delay expected
Better than expected
Capital raise
NYSE
10-Q: Albemarle Corp Reports Q1 2025 Results, Navigates Lithium Price Volatility with Cost Optimization
Albemarle Corporation's Q1 2025 results reflect a decrease in net sales due to lower lithium prices, offset by growth in Specialties and strategic cost-cutting measures.
Delay expected
Worse than expected
NYSE
Albemarle Corporation reported a substantial net loss for the third quarter of 2024, driven by lower lithium prices and significant restructuring charges.
Worse than expected
Delay expected
NYSE
Albemarle Corporation experienced a substantial net loss in the second quarter of 2024, primarily due to a sharp decline in lithium market prices and restructuring costs.
Worse than expected
Delay expected
Capital raise
Annual Reports (10-K)
NYSE
Albemarle Corporation filed an amendment to its 2025 Annual Report on Form 10-K to include the separate financial statements of its subsidiary, Windfield Holdings Pty Ltd, for the fiscal years ended December 31, 2025, 2024, and 2023.
Worse than expected
NYSE
Albemarle Corporation files an amendment to its 2024 annual report to include the financial statements of Windfield Holdings Pty Ltd as required by SEC regulations.
NYSE
10-K: Albemarle Corp Faces Lithium Price Volatility Amidst Strategic Restructuring: 2024 10-K Analysis
Albemarle Corporation navigates a challenging year marked by significant lithium price declines and strategic restructuring efforts aimed at optimizing costs and enhancing long-term competitiveness, as detailed in its 2024 10-K filing.
Worse than expected
Delay expected
NYSE
Albemarle Corporation has amended its annual report to include the financial statements of Windfield Holdings Pty Ltd, a subsidiary, which were not available at the time of the original filing.
Delay expected
NYSE
Albemarle Corporation has established a new policy to recover incentive compensation from executives in cases of misconduct or accounting restatements.
Insider Trading (Form 4)
NYSE
Bartolomeo Eduardo Desalles, a Director of Albemarle Corp, received 1,375 shares of common stock on July 21, 2026.
NYSE
Glenda J. Minor, a Director at Albemarle Corp, received an award of 1,250 phantom stock units on July 1, 2026, under the company's 2023 Directors Plan.
NYSE
Albemarle Corporation director Michelle T. Collins reported transactions involving common stock and accrued dividends, reflecting her compensation and ownership.
NYSE
Ralf Hans Cramer, a Director at Albemarle Corp, reported transactions involving the acquisition and disposition of common stock, including shares withheld for tax liabilities.
NYSE
Laurie Barlas, a Director at Albemarle Corp, acquired shares through director compensation and dividend settlement.
NYSE
Albemarle Corporation director Alejandro Daniel Wolff acquired common stock and phantom stock units as part of compensation and dividend reinvestment.
Proxy Statements (Def-14A)
NYSE
Albemarle Corporation reports robust 2025 financial and operational discipline, achieving significant cash flow and strategic portfolio enhancements despite dynamic market conditions.
Better than expected
NYSE
Albemarle Corporation has filed a definitive proxy statement with the SEC, indicating upcoming shareholder actions.
NYSE
Albemarle's 2025 proxy statement highlights the company's strategic response to lower lithium prices in 2024, including cost reduction programs and a shift in operational structure, while maintaining a commitment to shareholder engagement and sustainability.
Delay expected
Worse than expected
NYSE
Albemarle Corporation has filed a definitive proxy statement with the SEC, indicating upcoming shareholder actions.
NYSE
Albemarle Corporation's proxy statement details proposals for the upcoming annual shareholder meeting, including director elections, executive compensation, and an increase in authorized common stock.
Capital raise
Schedule 13G - Passive Investments
NYSE
Capital World Investors has reported a 9.5% stake in Albemarle Corp. as of March 31, 2026, holding over 11.2 million shares.
NYSE
Vanguard Capital Management has reported a beneficial ownership of 7.37% in Albemarle Corp's common stock as of March 31, 2026.
NYSE
Vanguard Portfolio Management has reported beneficial ownership of 5.38% of Albemarle Corporation's common stock as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Albemarle Corp following an internal realignment.
NYSE
Franklin Resources, Inc. has filed an amendment to its Schedule 13G, disclosing a 3.1% beneficial ownership stake in Albemarle Corporation as of December 31, 2025.
NYSE
Capital Research Global Investors has filed an amended Schedule 13G, reporting a 1.8% beneficial ownership stake in Albemarle Corp. common stock.